Albany Medical Center & New York Oncology Hematology Announce October Oncology Research Symposium CME Credits Available for 8th Annual Event Topics Focus on Breast, Lung Cancers and Tumors of Unknown Origin

Share Article

“Transforming Basic Science into Clinical Practice” is the theme of the 2014 Translational Oncology Research Symposium. This continuing medical education (CME) –certified conference will be held October 16th and 17th at the Hilton Garden Inn at Albany Medical Center.

“Transforming Basic Science into Clinical Practice” is the theme of the 2014 Translational Oncology Research Symposium. This continuing medical education (CME) –certified conference will be held October 16th and 17th at the Hilton Garden Inn at Albany Medical Center.

Hosted by Albany Medical College and New York Oncology Hematology, P.C. (NYOH), the region’s largest provider of cancer care, the 8th annual CME event is jointly provided by the Medical College of Wisconsin. The 2014 symposium will focus on breast and lung cancers, as well as tumors of unknown primary origin.

Friday morning’s keynote address features Carlos Arteaga, MD, the current president of the American Association for Cancer Research. Thursday evening’s keynote speaker is Vincent Miller, MD of Foundation Medicine, Cambridge, MA.

Vincent Verdile, MD, dean of Albany Medical College and executive vice president for health affairs at Albany Medical Center and Lawrence Garbo, MD, chairman of the NYOH Research Committee, will moderate the symposium.

Attendees can earn AMA PRA Category 1 Credits ™ by participating in this 1.5-day conference.

By bringing together local and national experts in clinical oncology and basic cancer research, the CME conference aims to raise awareness, build collaboration and foster translational oncology in the Capital and Adirondack regions of New York and beyond.

The symposium is co-chaired by Paul Higgins, PhD, and Paula McKeown-Longo, PhD, co-directors of Albany Med’s Center for Cell Biology and Cancer Research, and Karen Tedesco, MD, director of the NYOH Hereditary Cancer Risk Assessment Program. Dr. Tedesco also serves as the CME course director for this activity.

"Through laboratory based, translational, and clinical research collaboration between NYOH and Albany Medical Center, we continue to offer our patients personalized and innovative cancer treatments which lead to improved outcomes,” said Karen Tedesco, MD, Director of NYOH’s Hereditary Cancer Risk Assessment Program. “Together, we are providing patients with state-of the-art care – close to home."

The CME conference includes complimentary meals and snacks, as well as opportunities to view research poster presentations and exhibitor displays. Registration is $25. For more information or to register, visit

About New York Oncology Hematology
New York Oncology Hematology (NYOH) is the region’s leading provider of community-based cancer care and services. With seven convenient locations, a team of 36 physicians, and more than 300 oncology professionals, NYOH has been delivering world class cancer care to the Capital Region and surrounding communities for more than 30 years. Through its affiliation with The US Oncology Network, one of the nation’s largest cancer treatment and research networks, NYOH offers the latest breakthroughs, treatments, and technologies – right here at home.

About Albany Medical College
Albany Medical Center is northeastern New York’s only academic health sciences center and is one of the largest private employers in the Capital Region.

It incorporates the 734-bed Albany Medical Center Hospital, which offers the widest range of medical and surgical services in the region, and the Albany Medical College, which trains the next generation of doctors, scientists and other healthcare professionals, and which also includes a biomedical research enterprise and the region’s largest physicians practice with 425 doctors. Albany Medical Center works with dozens of community partners to improve the region’s health and quality of life.

Release Issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated advertising, marketing, and public relations and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.

Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.

Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.

To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email us at mwayne(at)audiencegeneration(dot)com or visit us at:

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Matt Wayne
Audience Generation
+1 512-708-4678
Email >